BACK TO MAIN  |  ONLINE BOOKSTORE  |  HOW TO ORDER

TWN Info Service on Intellectual Property (Nov26/02)
19 November 2026
Third World Network

WIPO:  SCP agrees to study health-licensing and technology transfer in collaborative projects

Geneva, 18 November (TWN) — The 38th session of the WIPO Standing Committee on the Law of Patents (SCP) decided to undertake studies on patent licensing in health and on collaborative technology transfer projects.

The SCP session took place on 2-6 November at the WIPO Headquarters in Geneva in a hybrid mode.

Proposals were presented in plenary on Thursday 5 November under item 10 (future work) and negotiated in informal discussions. The Chair's summary (item 11, now published as SCP/38/11) was agreed on Friday.

SCP/39, to be chaired by Esteban Figueroa of Chile, is tentatively set for 18 to 22 October 2027.

The final Chair's Summary reflected the negotiated outcome of informal discussions between Group B (developed countries) and developing country coalitions (African Group, Group of Latin American and Caribbean Countries or GRULAC, Asia Pacific Group, Central and Baltic States). This includes:

  • Technology Transfer: Agreed to two Secretariat studies focused on patent licensing — one on international collaborative health projects (SCP/39) and one on green technologies (SCP/40), along with a presentation on the WIPO Standard Essential Patents (SEPs) strategy (SCP/39);
  • Patents & Health: Agreed to an inclusive study on patent licensing contracts/arrangements in the health sector (SCP/39) and continued status updates on medical patent databases;
  • Quality of Patents & Artificial Intelligence (AI): Agreed to sharing sessions on AI examination tools/safeguards (SCP/39) and sufficiency of disclosure (SCP/39), as well as updating the DABUS case compilation (SCP/40) with the 10-country joint inventorship paper led by Australia.
  • Client-Adviser Confidentiality: Agreed to a Group B-proposed panel discussion for `SCP/39`.

Brazil vs. United States: Debate on Document References under "Patents and Health"

A major exchange occurred on the last day between Brazil and the US over the wording in paragraph 18 of the draft Chair's Summary.

Brazil noted that while other sections stated “discussions were based on documents” paragraph 18 under the agenda item on Patents and Health originally read “discussions were aligned with documents”. Brazil requested adopting the standard phrasing “discussions were based on documents...”. Furthermore, it insisted on keeping references to older foundational documents (such as SCP/16/7 and SCP/24/4) because developing country delegations had explicitly recalled them during plenary statements.

The US objected to using the phrase “based on” for those older documents. It stated that plenary discussions were not actively based on unapproved or old proposals from prior years and warned that such wording created a false impression of the committee's work. The US proposed either changing the verb to “discussions mentioned” or “referenced” the documents, or else adding the US's own historical proposal (`SCP/17/11`) to the list.

After clarification that the US proposal was raised in closed informal discussions rather than recorded plenary minutes, the Chair proposed changing the verb to “discussions mentioned”. Both Brazil and the US accepted this compromise.

Omitted Proposals

Several proposals did not find consensus and were therefore omitted from future work. On China’s outer-space proposal (SCP/38/10) it records “no consensus on the adoption of the proposal”, with one Member State opposed, and says the Committee “will further discuss the proposal at the next session”.

The Chair's Summary recorded the final positions of China and the US regarding China's proposal to exchange information on intellectual property protection in outer space activities:

China (supported by Pakistan, Russia, Kazakhstan, Iran and Brazil) sought to establish information-sharing and an expert workshop on outer space patent practices at SCP/39.

The US maintained firm opposition, arguing that outer space IP fell outside patent quality and the Committee's mandate, while creating resource constraints for the Secretariat. It also cited “the resource constraints on the Secretariat”.

Paragraph 14 of the Chair's Summary officially recorded that “there was no consensus on the adoption of the proposal” due to opposition by one Member State (the US), but noted that the Committee “will further discuss the proposal at the next session, with one Member State opposing”.

The African Group’s proposal for a comprehensive WIPO technical assistance toolkit/portal under Exceptions & Limitations and a study on anticompetitive licensing practices were excluded due to lack of consensus from Group B.

Haiti, for GRULAC, welcomed the African Group proposals saying these were “firmly grounded in the SCP's existing mandate” and backed “a wide portal consolidating existing SCP studies and reference documents”. It also criticised the session's time allocation: “While more than a full day was devoted to discussions related to artificial intelligence, less than half a day was allocated to patents and health and even less time to exceptions and limitations to patent rights.”

Brazil gave “full support to all the four proposals”. Singapore, for the Asia-Pacific Group, gave “general support for the four proposals from the African Group, particularly the proposals on AI and patents and patents and health”.

The Asia-Pacific Group and Brazil backed all four African Group proposals, and GRULAC backed its toolkit and AI proposals. However, Group B had “a number of questions and concerns with several of the proposals”.

 The CEBS Group’s proposal for a comparative study on generative AI examination workloads was also omitted from the final Chair's Summary. Singapore for the Asia-Pacific Group asked for “additional background on the genesis of the proposal”.

Brazil’s Concerns on Technology Transfer Studies

The study under SCP/38/9 covers best practices and challenges in technology transfer in health and green technology, with focus on industry–academia collaboration. It rests on inputs from eight Member States and three consultants (paragraph 3) and defines technology transfer, for its analysis, as moving publicly funded research into private commercialisation, mainly through IP protection, licensing and spin-outs (paragraph 15).

The eight Member States that submitted under agenda item (vi) were Australia, Ecuador, Egypt, El Salvador, France, Japan, Slovakia and Switzerland. The three consultants were Mr Joy Goswami (Director, Intellectual Property & Licensing, Office of Innovation & Partnerships, State University of New York Research Foundation, US), Prof. Dr Fazilet Vardar (Coordinator for Research Partnerships and Innovation, Izmir University of Economics, Türkiye) and Ms Varinka Farren, RTTP (Executive Director, HUB APTA, Chile).

Brazil raised concerns regarding the scope, the framing and the methodology of the presented study. First, it said, “… the study does not sufficiently address the public dimension, the public good dimension of the areas under consideration, namely public health and sustainable development”.

Second, pointing to the ambiguities in the report, Brazil asked for “… greater conceptual precision in the terminology adopted for green technologies”.

Third, Brazil stated that the “… report is too narrowly and unduly focused on voluntary licensing, contractual arrangements and collaboration between academic institutions and private companies.  Technology transfer takes place for different legal and policy mechanisms. It is important that the study also recognize the role of the flexibilities available under international intellectual property law including compulsory licensing which can constitute a legitimate mechanism for facilitating access to and the use of IP protected technology when addressing climate change and public health challenges. A comprehensive understanding of technology transfer should not overlook this mechanism, particularly when examining the contribution of the patent system to the public interest and to sustainable development”.

Four, on the geographically unbalanced approach of the report, Brazil said the report considered certain regions without any explanation for such selection. For instance, Latin America was treated in green technology but not health.

Five, Brazil pointed that the study is not robust because it fails to “… meaningfully incorporate the potential implications of artificial intelligence for technology transfer…”.

Third World Network (TWN) aligned with Brazil. It said SCP/38/9 defines technology transfer narrowly and without regard for public interest (paragraph 15), draws a lesson on speed, not access, from Operation Warp Speed (paragraph 51), and that SCP/38/8 Corr is framed around innovators' challenges.

Access, TWN said, should be at the heart of such studies, because a patent monopoly carries an implied agreement to facilitate access to technology. It stressed that few new medicines are marketed in developing countries, and late: for essential medicines, the median wait after the first global launch is 2.7 years in high-income countries, 6.9 in lower-middle-income countries and 8.0 in low-income countries. Compulsory licences work only where a country can make the product and its ingredients; where that capacity is missing, supply stays with the patent holder.

TWN added that pressure outside the Committee closes the same routes, citing bilateral political pressures by the US on developing countries that use TRIPS flexibilities such as compulsory licensing as a tool of industrial policy. It asked the Committee to place access to technology, access terms and manufacturing capacity at the centre of item 9 of the SCP agenda, and to widen the item beyond downstream innovation.

 


BACK TO MAIN  |  ONLINE BOOKSTORE  |  HOW TO ORDER